Financial reports
Current reports
6-K/A
Current report (foreign) (amended)
24 Jun 24
6-K
Current report (foreign)
20 Jun 24
6-K
Current report (foreign)
24 May 24
6-K/A
Current report (foreign) (amended)
25 Apr 24
6-K
Current report (foreign)
24 Apr 24
6-K
CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies
18 Mar 24
6-K
Current report (foreign)
4 Mar 24
6-K
Malaysian Patent Granted for CytoMed Therapeutics’ Licensed Allogeneic CAR-Gamma Delta T Cell Technology
29 Jan 24
6-K
Current report (foreign)
17 Nov 23
6-K
Chinese Patent Granted for CytoMed Therapeutics’ Licensed iPSC-based Technology
25 Sep 23
Registration and prospectus
424B4
Prospectus supplement with pricing info
17 Apr 23
FWP
Free writing prospectus
31 Mar 23
8-A12B
Registration of securities on exchange
30 Mar 23
F-1/A
Registration statement (foreign) (amended)
30 Mar 23
F-1/A
Registration statement (foreign) (amended)
27 Mar 23
F-1/A
Registration statement (foreign) (amended)
15 Mar 23
FWP
Free writing prospectus
27 Feb 23
F-1/A
Registration statement (foreign) (amended)
21 Feb 23
F-1/A
Registration statement (foreign) (amended)
31 Jan 23
F-1
Registration statement (foreign)
18 Nov 22
Proxies
No filings
Other
CERT
Certification of approval for exchange listing
14 Apr 23
EFFECT
Notice of effectiveness
3 Apr 23
CORRESP
Correspondence with SEC
31 Mar 23
CORRESP
Correspondence with SEC
31 Mar 23
CORRESP
Correspondence with SEC
31 Mar 23
SEC STAFF
SEC staff action: Order
31 Mar 23
CORRESP
Correspondence with SEC
30 Mar 23
UPLOAD
Letter from SEC
29 Mar 23
CORRESP
Correspondence with SEC
15 Mar 23
UPLOAD
Letter from SEC
24 Feb 23